======= MINPP1 ======= == Gene Information == * **Official Symbol**: MINPP1 * **Official Name**: multiple inositol-polyphosphate phosphatase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9562|9562]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UNW1|Q9UNW1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MINPP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MINPP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605391|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes multiple inositol polyphosphate phosphatase; an enzyme that removes 3-phosphate from inositol phosphate substrates. It is the only enzyme known to hydrolzye inositol pentakisphosphate and inositol hexakisphosphate. This enzyme also converts 2,3 bisphosphoglycerate (2,3-BPG) to 2-phosphoglycerate; an activity formerly thought to be exclusive to 2,3-BPG synthase/2-phosphatase (BPGM) in the Rapoport-Luebering shunt of the glycolytic pathway.[provided by RefSeq, Sep 2009]. * **UniProt Summary**: Acts as a phosphoinositide 5- and phosphoinositide 6- phosphatase and regulates cellular levels of inositol pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6). Also acts as a 2,3-bisphosphoglycerate 3-phosphatase, by mediating the dephosphorylation of 2,3-bisphosphoglycerate (2,3-BPG) to produce phospho-D-glycerate without formation of 3- phosphoglycerate. May play a role in bone development (endochondral ossification). May play a role in the transition of chondrocytes from proliferation to hypertrophy (By similarity). {ECO:0000250|UniProtKB:F1NPQ2, ECO:0000269|PubMed:18413611}. |His Phos 2| |inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity| |bisphosphoglycerate 3-phosphatase activity| |inositol hexakisphosphate 2-phosphatase activity| |inositol phosphate phosphatase activity| |inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity| |protein histidine phosphatase activity| |polyphosphate metabolic process| |acid phosphatase activity| |bone mineralization| |inositol phosphate metabolic process| |biomineral tissue development| |biomineralization| |polyol metabolic process| |protein dephosphorylation| |ossification| |endoplasmic reticulum lumen| |dephosphorylation| |alcohol metabolic process| |organic hydroxy compound metabolic process| |organophosphate metabolic process| |oxoacid metabolic process| |endoplasmic reticulum| |organic acid metabolic process| |small molecule metabolic process| |tissue development| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|1.98| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.437| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2994 * **Expression level (log2 read counts)**: 3.05 {{:chemogenomics:nalm6 dist.png?nolink |}}